Ty virus-like particles, DNA vaccines and modified vaccinia virus Ankara; Comparisons and combinations

Sarah C. Gilbert, Jörg Schneider, Magdalena Plebanski, Carolyn M. Hannan, Tom J. Blanchard, Geoff L. Smith, Adrian V S Hill

Research output: Contribution to journalArticleResearchpeer-review

32 Citations (Scopus)


Three types of vaccine, all expressing the same antigen from Plasmodium berghei, or a CD8+ T cell epitope from that antigen, were compared for their ability to induce CD8+ T cell responses in mice. Higher levels of lysis and numbers of IFN-γ secreting T cells were primed with Ty virus-like particles and Modified Vaccinia Virus Ankara (MVA) than with DNA vaccines, but none of the vaccines were able to protect immunised mice from infectious challenge even after repeated doses. However, when the immune response was primed with one type of vaccine (Ty-VLPs or DNA) and boosted with another (MVA) complete protection against infection was achieved. Protection correlated with very high levels of IFN-γ secreting T cells and lysis. This method of vaccination uses delivery systems and routes that can be used in humans and could provide a generally applicable regime for the induction of high levels of CD8+ T cells.

Original languageEnglish
Pages (from-to)299-303
Number of pages5
JournalBiological Chemistry
Issue number3
Publication statusPublished - Mar 1999
Externally publishedYes


  • Cytotoxic T cells
  • DNA vaccine
  • Malaria
  • Modified vaccinia virus Ankara
  • Virus-like particles

Cite this